Measuring school functioning in students with CFS

Review abstract:

Measuring school functioning in students with Chronic Fatigue Syndrome: a systematic review, by Michelle Tollit, Jennifer Politis, Sarah Knight in J Sch Health. 2018 Jan; 88(1):74-89. [published online 17 Dec 2017]

BACKGROUND: It is often surmised that school functioning is significantly impacted in chronic fatigue syndrome (CFS); however, how this phenomenon manifests itself has rarely been characterized.

METHODS: This systematic review synthesized and critically appraised methods, constructs, and instruments used to assess school functioning in students with CFS. Searches were conducted in electronic databases (CINAHL, MEDLINE, PubMed, ERIC, and PsycINFO) to locate empirical studies that measured school functioning in children and adolescents with CFS.

RESULTS: A total of 36 papers met the inclusion criteria. By far the most commonly reported school functioning construct measured related to school attendance. This was followed by academic functioning, achievement motivation, and educational services received. Little consistency was found in the measurement of these constructs across studies.

CONCLUSIONS: The current review revealed that the school experiences of children and adolescents with CFS have rarely been characterized beyond school absenteeism. Improvements in current assessment methods are required to comprehensively understand the impact of CFS on school functioning. Completely understanding the multiple aspects of school functioning will help to inform targeted strategies to optimize educational outcomes for students with CFS.

Posted in News | Tagged , , , , , , , , | Comments Off on Measuring school functioning in students with CFS

Cytokine signatures in CFS patients: a Case Control Study & the effect of anakinra treatment

Research abstract:

Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment, by Megan E. Roerink, Hans Knoop, Luuk J. A. C. Hawinkels, Leo A. B. Joosten and Jos W. M. van der Meer in Journal of Translational Medicine 2017 15:267

Background:
Cytokine disturbances have been suggested to be associated with the Chronic Fatigue Syndrome/Myalgic encephalomyelitis (CFS/ME) for decades.

Methods:
Fifty female CFS patients were included in a study on the effect of the interleukin-1-receptor antagonist anakinra or placebo during 4 weeks. EDTA plasma was collected from patients before and directly after treatment. At baseline, plasma samples were collected at the same time from 48 healthy, age-matched female neighborhood controls. A panel of 92 inflammatory markers was determined in parallel in 1 μL samples using a ‘proximity extension assay’ (PEA) based immunoassay. Since Transforming growth factor beta (TGF-β) and interleukin-1 receptor antagonist (IL-1Ra) were not included in this platform, these cytokines were measured with ELISA.

Results:
In CFS/ME patients, the ‘normalized protein expression’ value of IL-12p40 and CSF-1 was significantly higher (p value 0.0042 and 0.049, respectively). Furthermore, using LASSO regression, a combination of 47 markers yielded a prediction model with a corrected AUC of 0.73. After correction for multiple testing, anakinra had no effect on circulating cytokines. TGF-β did not differ between patients and controls.

Conclusions:
In conclusion, this study demonstrated increased IL-12p40 and CSF-1 concentrations in CFS/ME patients in addition to a set of predictive biomarkers. There was no effect of anakinra on circulating cytokines other than IL-1Ra.

Trial Registration: ClinicalTrials.gov Identifier: NCT02108210, Registered April 2014

 

Posted in News | Tagged , , , , , , , , , | Comments Off on Cytokine signatures in CFS patients: a Case Control Study & the effect of anakinra treatment

CFS/ME symptom-based phenotypes & 1 year treatment outcomes in UK & Netherlands

Research abstract:

Chronic fatigue syndrome (CFS/ME) symptom-based phenotypes and 1-year treatment outcomes in two clinical cohorts of adult patients in the UK and The Netherlands, by  Simon M. Collin, Jon Heron, Stephanie Nikolaus, Hans Knoop, Esther Crawley in Journal of Psychosomatic Research Vol. 104, pp 29-34, January 2018

Highlights:

  • we previously described symptom based CFS/ME phenotypes in UK and Dutch patients.
  • These phenotypes were replicated in the new UK patient cohort.
  • Patients with multiple symptoms or pain or less likely to respond to treatment.
  • The same phenotypes and associations were observed in UK and Dutch patients.
  • The associations were robust to adjustment for severity of illness.

Objective:
We previously described symptom-based chronic fatigue syndrome (CFS/ME) phenotypes in clinical assessment data from 7041 UK and 1392 Dutch adult CFS/ME patients. Here we aim to replicate these phenotypes in a more recent UK patient cohort, and investigate whether phenotypes are associated with 1-year treatment outcome.

Methods:
12 specialist CFS/ME services (11 UK, 1 NL) recorded the presence/absence of 5 symptoms (muscle pain, joint pain, headache, sore throat, and painful lymph nodes) which can occur in addition to the 3 symptoms (post-exertional malaise, cognitive dysfunction, and
disturbed/unrefreshing sleep) that are present for almost all patients. Latent Class Analysis (LCA) was used to assign symptom profiles (phenotypes). Multinomial logistic regression models were fitted to quantify associations between phenotypes and overall change in health 1 year after the start of treatment.

Results:
Baseline data were available for N=918 UK and N=1392 Dutch patients, of whom 416 (45.3%) and 912 (65.5%) had 1-year follow-up data, respectively. 3- and 4-class phenotypes identified in the previous UK patient cohort were replicated in the new UK cohort. UK patients who presented with ‘polysymptomatic’ and ‘pain-only’ phenotypes were 57% and 67% less likely (multinomial odds ratio (MOR) 0.43 (95% CI 0.19-0.94)
and 0.33 (95% CI 0.13-0.84)) to report that their health was ‘very much better’ or ‘much better’ than patients who presented with an ‘oligosymptomatic’ phenotype. For Dutch patients, polysymptomatic and pain-only phenotypes were associated with 72% and 55% lower odds of improvement (MOR 0.28 (95% CI 0.11, 0.69) and 0.45 (95% CI 0.21, 0.99))
compared with oligosymptomatic patients.

Conclusions:
Adult CFS/ME patients with multiple symptoms or pain symptoms who present for specialist treatment are much less likely to report favourable treatment outcomes than patients who present with few symptoms.

Posted in News | Tagged , , , , , , , | Comments Off on CFS/ME symptom-based phenotypes & 1 year treatment outcomes in UK & Netherlands

Guidelines for children with ME now available to download

Myalgic Encephalomyelitis Chronic Fatigue Syndrome Diagnosis and Management in Young People: a primer, 2017 Edition

This primer was compiled and published in June 2017 by the International Writing Group for Pediatric ME/CFS. It was originally published as a review article based in Frontiers in Pediatrics on 19 June 2017 and will be published as a printable monograph version which will contain an index, and have a cover containing original artwork created by a young person with ME/CFS.

In the meantime the international team of authors (which includes our advisor Dr Nigel Speight) are keen that the primer is distributed and used free of charge.

Download

This primer has been written to provide the information necessary to understand, diagnose, and manage the symptoms of ME/CFS in children and adolescents.

 

Authors:

Peter C. Rowe, Rosemary A. Underhill, Kenneth J. Friedman, Alan Gurwitt, Marvin S. Medow, Malcolm S. Schwartz, Nigel Speight, Julian M. Stewart, Rosamund Vallings and Katherine S. Rowe.

 

Posted in News | Tagged , , , , , , , , , , , , , , , | Comments Off on Guidelines for children with ME now available to download

Time for Unrest: Why patients with ME are demanding justice

Independent: Time for Unrest: Why patients with ME are demanding justice, by Nathalie Wright, 7 Jan 2018

A new film sheds light on a condition that is largely ignored. Nathalie Wright reports on the struggles patients face to be taken seriously by doctors.

“I feel seen for the first time!” exalts one viewer. “I feel vindicated. I finally understand what’s wrong with me, I think I’ve had this all my life,” says another. A doctor admits, “I feel so ashamed.”

The film in question is Unrest, a documentary directed by and featuring Jennifer Brea, a former Harvard PHD student who, after developing the disease ME, started filming her experience. For those not directly affected by the illness, their go-to reference may be one of the many stereotypes that have proliferated in the British media: ME is “yuppie flu”; it’s an illness of lazy people or type-A personalities, malingerers, hysterical women, militant activists, scroungers, even people who are “a bit tired” and “don’t feel like going to work today” (according to a Ricky Gervais standup routine). For the first time, a major documentary is speaking back to decades of misinformation and showing what often doctors don’t even see: the daily life of sufferers, of whom there are about 260,000 in the UK.

Unrest follows Brea when she first becomes sick after a 40C fever. For the next year, she suffers repeated infections and her health declines dramatically. But doctors do not take her seriously – a state of play recognised by many young women who are dismissed by the medical system. When she finally sees a neurologist, he diagnoses “conversion disorder”. Hysteria. There must be a trauma that she can’t even remember. There is nothing physically wrong with her that could be causing her symptoms. And so, Brea decides to walk the two miles home – what could be the harm after all? When she arrives back, her brain and spinal cord feel like they are on fire. She is bed bound for the next two years and now, several years later, uses a wheelchair.

After eventually being diagnosed with ME, Brea was able to access some treatments in her native US, but there currently are no cures. Like most patients, an initial flu-like illness triggered the disease. Her symptoms include profound exhaustion (utterly unlike everyday “tiredness”), extreme pain and a worsening of symptoms after even minimal exertion – a symptom known as post-exertional malaise or PEM. ME, like autoimmune diseases, mainly affects women and is often developed in the prime of life, though children are also affected. Indeed, it is the biggest cause of long-term sickness absence from school. Since 1969, the World Health Organisation has recognised ME as a neurological illness although its precise mechanisms remain unknown.

Jessica Taylor, bedridden with severe ME since she was 15, has her makeup done by her sister (Shella Films)

The film features other stories too. Jessica, a young British woman spent four years from the age of 14 in hospital in a semi-coma because of ME. She improved slightly but was completely bedridden such that her feet didn’t touch the ground for years, during which time she grew four inches. “I’ve never stood up at my full height,” she explains matter-of-factly. In contrast, a very severe patient, Whitney, is completely unable to speak. He is so sensitive to stimulation that it is dangerous for others to even be in the same room as him. Fed by a tube in his small intestine, he passes his life in darkness and silence, unable to tolerate light or sound.

Such stories of extreme physical debility are not, however, the most shocking part of the documentary. What has prompted a global justice movement is the fact that many doctors still refuse to accept that ME exists at all.

The article gives a long but excellent summary of the history of ME in the UK and then looks at important research developments which have produced insights into the biomedical nature of ME, before focussing on the  campaign:

ME patients have always had to fight for their rights, but now with the advent of social media, bed-bound patients are able to connect globally and a social justice movement is flourishing under the twitter hashtag #MillionsMissing.

For Jennifer Brea, ME activists can learn a lot from history.

“To fight stigma and to force the recognition from the health system, we need a movement for access to treatment, care and research. The HIV/Aids movement allowed extraordinary advancements in the space of a decade. That’s what we need here. It is about reclaiming our bodies and our experience; having a sense of pride in ourselves an in each other.”

And the movement is beginning to gather momentum. In the UK, the NHS has announced it will completely rewrite its guidelines for ME, after pressure from patients and concerned scientists. Medical research into biomedical causes is increasing, but remains seriously underfunded globally.

“It’s 30 years wasted, which is a long time in research terms. We could have discovered the cause of ME in that time,” laments health researcher, Dr Keith Geraghty.

Historically, people with ME have been excluded from the disability rights movements in the UK and did not have the lobbying power to affect government policy but disability and ME activists alike are starting to come together, uniting under the slogan: “Nothing about us without us”.

“ME activists are so distressed and angry because we’ve had our reality denied by almost everyone around us,” explains Catherine Hale, an ME activist and leader of the Chronic Illness Inclusion Project. “The dismissal of our testimony is profoundly distressing, you can develop a PTSD response from it. It’s a kind of abuse. A treatment approach that harms people by saying it is our mindset that needs to be changed is a very oppressive experience. As patients, we’ve all been so isolated and are too ill to go out and protest and that’s why the ‘Millions Missing’ is really in its infancy, because we’ve come from so far down.”

Adam Lowe, an author and journalist with ME is also demanding accountability.

“One of the most common misconceptions about ME patients is that we’re anti-psychiatry and resent all treatments that imply even a partially psychological cause for the illness. This is another myth that needs to be challenged. I’m a strong believer in adequate mental health provision for everyone as are most ME patients.

“We live with this illness in the dark, hidden in our bedrooms, desperate for answers. We can’t get proper treatment because they tie up limited national resources in endless, useless studies that conflate long-term fatigue with the very specific neuroimmune illness ME. They continue to harm and insult us, the way the LGBT and civil rights movements were harmed, denigrated and insulted in decades past. They are institutionally ableist in the way the Met was once labelled institutionally racist after the Stephen Lawrence inquiry. The only difference is that we die quietly, in the back rooms of our house, because of lack of proper care or effective treatment. No one sees, so the outrage is confined to those of us who know – those of us who already have this illness, and those who love and care for us.”

“Eventually, I think, the small cabal of people setting the negative medical and social narratives about ME will have to wake up and apologise for the harms they’ve caused to hundreds of thousands of people – just like psychiatrists recently apologised to LGBT people. History will not show them favourably, because I believe that justice will prevail in the end.”

Unrest has recently been shortlisted for an Oscar. The power of documentary film is that viewers are confronted by what is unseen – or ignored; it is a medium that conveys something words cannot. Maybe, finally, ME patients are beginning to be seen.

Unrest is being screened in selected cinemas around the UK and is available to watch online.

Read the full article

Read Simon Wessely’s response to Nathalie Wright

Posted in News | Tagged , , , , | Comments Off on Time for Unrest: Why patients with ME are demanding justice

Transforming growth factor beta (TGF-β) in adolescent CFS

Research abstract:

Transforming growth factor beta (TGF-β) in adolescent chronic fatigue syndrome by VB Wyller, CB Nguyen, JA Ludviksen, TE Mollnes in J Transl Med. 2017 Dec 4;15(1):245

BACKGROUND:
Chronic fatigue syndrome (CFS) is a prevalent and disabling condition among adolescents. The disease mechanisms are unknown. Previous studies have suggested elevated plasma levels of several cytokines, but a recent meta-analysis of 38 articles found that of 77 different cytokines measured in plasma, transforming growth factor beta (TGF-β) was the only one that was elevated in patients compared to controls in a sufficient number of articles.

In the present study we therefore compared the plasma levels of the three TGF-β isoforms in adolescent CFS patients and healthy controls. In addition, the study explored associations between TGF-β levels, neuroendocrine markers, clinical markers and differentially expressed genes within the CFS group.

METHODS:
CFS patients aged 12-18 years (n = 120) were recruited nation-wide to a single referral center as part of the NorCAPITAL project (ClinicalTrials ID: NCT01040429). A broad case definition of CFS was applied, requiring 3 months of unexplained, disabling chronic/relapsing fatigue of new onset, whereas no accompanying symptoms were necessary. Healthy controls (n = 68) were recruited from local schools.

The three isoforms of TGF-β (TGF-β1, TGF-β2, TGF-β3) were assayed using multiplex technology. Neuroendocrine markers encompassed plasma and urine levels of catecholamines and cortisol, as well as heart rate variability indices. Clinical markers consisted of questionnaire scores for symptoms of post-exertional malaise, inflammation, fatigue, depression and trait anxiety, as well as activity recordings. Whole blood gene expression was assessed by RNA sequencing in a subgroup of patients (n = 29) and controls (n = 18).

RESULTS:
Plasma levels of all three isoforms of TGF-β were equal in the CFS patients and the healthy controls. Subgrouping according to the Fukuda and Canada 2003 criteria of CFS did not reveal differential results. Within the CFS group, all isoforms of TGF-β were associated with plasma cortisol, urine norepinephrine and urine epinephrine, and this association pattern was related to fatigue score. Also, TGF-β3 was related to expression of the B cell annotated genes TNFRSF13C and CXCR5.

CONCLUSIONS:
Plasma levels of all TGF-β isoforms were not altered in adolescent CFS. However, the TGF-β isoforms were associated with neuroendocrine markers, an association related to fatigue score. Furthermore, TGF-β3 might partly mediate an association between plasma cortisol and B cell gene expression. Trial registration Clinical Trials NCT01040429.

 

 

Posted in News | Tagged , , , , , , , , , , | Comments Off on Transforming growth factor beta (TGF-β) in adolescent CFS

Solve ME/CFS Initiative list major research highlights of 2017

Solve ME/CFS Initiative blog post: 2017 ME/CFS Research Highlights – Study Developments on our Radar, 21 December 2017

In this December Research 1st e-newsletter, we highlight important advances in the ME/CFS field from 2017. These advances build on promising research and reflect the dynamic momentum occurring on all fronts. Many of these studies are interdisciplinary and have relevance in more than one category. They are not listed in any specific order.

1. Major Collaborative Efforts

2. Improved study design creating more definitive conclusions

3. Immunity/inflammation

4. Neuroendocrine Biology

5. Energy System Defects

6. Gut microbiome

7. Epigenetics

8. Clinical Research

The research and discovery process is multifaceted and costly. The Solve ME/CFS Initiative is committed to accelerating progress and, despite our modest budget, we have made great strides to fund innovative science and discovery projects in biologics, capacity building, and ME/CFS infrastructure development. We are currently operating five SMCI-Directed research projects with prestigious partners at seven universities and biotech companies and funding ten Ramsay Award Program research teams from twelve universities in seven countries, across four continents.

Read more

Posted in News | Tagged , | Comments Off on Solve ME/CFS Initiative list major research highlights of 2017

Merry Christmas from WAMES

 

Posted in News | 1 Comment

Unrest Store UK now open

The UK Unrest shop is finally open.

You can pre-order Unrest on DVD and Blu-ray to enjoy from the comfort of your home, couch, or bed!

Jen & Omar – clip from Unrest film

Give the gift of Unrest to your friends and family this holiday season. Every purchase you make helps them sustain the #TimeForUnrest campaign to bring Unrest to medical schools, leading research institutions, and communities around the world.

BUY UNREST ON DVD & BLU-RAY

Orders ship from London across the United Kingdom and to Europe 18th December.

You can also check out the US store for  Unrest-themed apparel and collectibles.

Due to manufacturing constraints, branded merchandise, including t-shirts, hoodies, tote bags, posters and buttons, is currently sold only through the international store.  Please note that international shipping rates apply.

 

 

Posted in News | Tagged , , , | Comments Off on Unrest Store UK now open

Download a donation reminder for free donations to WAMES

Get an Easyfundraising donation reminder

If you shop online through your desktop or laptop get the easyfundraising donation reminder and you won’t forget to raise funds for WAMES at no cost to yourself.

Fundraisers with donation reminders raise 5 times more!

https://www.easyfundraising.org.uk/causes/wames/

Posted in News | Tagged | Comments Off on Download a donation reminder for free donations to WAMES